Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1101 of 1,261
  1. US 7115260

    Interleukin-1Ξ² converting enzyme like apoptotic protease-6

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Oct 3, 2006 Β· Expires Sep 28, 2026

    granted
  2. US 7115280

    Particle formation methods and their products

    Nektar Therapeutics UK, Ltd Β· Granted Oct 3, 2006 Β· Expires Sep 28, 2026

    granted
  3. US 7115405

    Hyaluronan synthase gene and uses thereof

    The Board of Regents of the University of Oklahoma Β· Granted Oct 3, 2006 Β· Expires Sep 28, 2026

    granted
  4. US 7115262

    Chimeric protein for prevention and treatment of HIV infection

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 3, 2006 Β· Expires Sep 28, 2026

    granted
  5. US 7115637

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated Β· Granted Oct 3, 2006 Β· Expires Sep 28, 2026

    granted
  6. US 7112341

    Pulmonary administration of dry powder formulations for treating infertility

    Nektar Therapeutics Β· Granted Sep 26, 2006 Β· Expires Sep 21, 2026

    granted
  7. US 7112317

    Combined methods and compositions for tumor vasculature targeting and tumor treatment

    The Board of Regents of the University of Texas System Β· Granted Sep 26, 2006 Β· Expires Sep 21, 2026

    granted
  8. US 7112574

    C2,8-disubstituted adenosine derivatives and their different uses

    CAN-FITE BIOPHARMA LTD. Β· Granted Sep 26, 2006 Β· Expires Sep 21, 2026

    granted
  9. US 7112415

    Method of preparing cell cultures from biological specimens for assaying a response to an agent

    Precision Therapeutics, Inc. Β· Granted Sep 26, 2006 Β· Expires Sep 21, 2026

    granted
  10. US 7112566

    Systemic administration of Hypocretin-1

    The Regents of the University of California Β· Granted Sep 26, 2006 Β· Expires Sep 21, 2026

    granted
  11. US 7112442

    Peptides for gene delivery

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Sep 26, 2006 Β· Expires Sep 21, 2026

    granted
  12. US 7112342

    Enriched platelet wound healant

    Cytomedix, Inc. Β· Granted Sep 26, 2006 Β· Expires Sep 21, 2026

    granted
  13. US 7112338

    Cationic liposome delivery of taxanes to angiogenic blood vessels

    The Regents of the University of California Β· Granted Sep 26, 2006 Β· Expires Sep 21, 2026

    granted
  14. US 7112332

    Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides

    The United States of America as represented by the Secretary of the Army Β· Granted Sep 26, 2006 Β· Expires Sep 21, 2026

    granted
  15. US 7109380

    Cyclopentenedione antifungal compounds and methods for their use

    The United States of America, as represented by the Secretary of Agriculture Β· Granted Sep 19, 2006 Β· Expires Sep 14, 2026

    granted
  16. US 7108975

    Atlastin

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Sep 19, 2006 Β· Expires Sep 14, 2026

    granted
  17. US 7108986

    Glypican-1 in human breast cancer

    The Regents of the University of California Β· Granted Sep 19, 2006 Β· Expires Sep 14, 2026

    granted
  18. US 7109011

    Hyaluronan synthase gene and uses thereof

    The Board of Regents of the University of Oklahoma Β· Granted Sep 19, 2006 Β· Expires Sep 14, 2026

    granted
  19. US 7108981

    Specific binding agents for KSHV vIL-6 that neutralize a biological activity

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Sep 19, 2006 Β· Expires Sep 14, 2026

    granted
  20. US 7109179

    Methods and compositions comprising DNA damaging agents and p53

    The Board of Regents of the University of Texas System Β· Granted Sep 19, 2006 Β· Expires Sep 14, 2026

    granted
  21. US 7109200

    Carbamate derivatives, process for producing the same and use thereof

    Takeda Pharmaceutical Company Limited Β· Granted Sep 19, 2006 Β· Expires Sep 14, 2026

    granted
  22. US 7109188

    Methods and compositions for treating atheroma, tumors and other neoplastic tissue

    The Board of Regents of the University of Texas System Β· Granted Sep 19, 2006 Β· Expires Sep 14, 2026

    granted
  23. US 7109245

    Vasoconstrictor cannabinoid analogs

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Sep 19, 2006 Β· Expires Sep 14, 2026

    granted
  24. US 7109215

    Compounds possessing neuronal activity

    Vertex Pharmaceuticals Incorporated Β· Granted Sep 19, 2006 Β· Expires Sep 14, 2026

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.